Skip to content
Homepage
Author:
PorTal Access, Inc
Posted Date:
June 22, 2026
PorTal Access Announces FDA Clearance of FLEXI-PORT™ family of implantable vascular access ports
PorTal Access, Inc
June 22, 2026
PorTal Access, Inc. Announces Completion of FDA 510(k) Submission for Flexi-Port™, Marking Major Milestone Toward Commercial Launch
PorTal Access, Inc
May 18, 2026
PorTal Access, Inc. Appoints Industry Veteran David Snow to Board of Directors to Advance Next-Generation Oncology Vascular Access Solutions
PorTal Access, Inc
February 23, 2026
